CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 4 Planned sale Chief Medical Officer sold 11,914 shares at an average $37.99 ($452,601)
- 144 Insider Sale of Securities
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 144 Insider Sale of Securities
- 8-K Event Executive or director change
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Planned sale Chief Medical Officer sold 4,091 shares at $34.17 ($139,789)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Legal Officer sold 2,799 shares at $33.54 ($93,878)
- 4 Planned sale Chief Medical Officer sold 2,909 shares at $33.54 ($97,568)
- 4 Planned sale Chief Financial Officer sold 1,780 shares at $33.54 ($59,701)
- 4 Planned sale Chief Commercial Officer sold 2,770 shares at $33.54 ($92,906)
- 4 Planned sale Chief Executive Officer sold 18,700 shares at $33.54 ($627,198)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Option exercise Director acquired 2,120 shares (option exercise)
Page 7 of 66 · 1,304 filings